Advantis (OTCPK:ADVT) - Stock Price, News & Analysis

ADVT Stock Overview

Develops and markets products focusing on medical cannabis, research, and pharmaceutical sectors. More details

ADVT fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($878)

Latest financial reports are more than a year old

Shares are highly illiquid

Advantis Corp. Competitors

Item 9 Labs

OTCPK:INLB

US$701.0

BZAM

OTCPK:BZAM.F

US$270.0

Clever Leaves Holdings

OTCPK:CLVR

US$1.0

Juva Life

OTCPK:JUVA.F

US$164.0

Price History & Performance

Summary of all time highs, changes and price drops for Advantis
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.0001
52 Week Low	US$0.000001
Beta	0
11 Month Change	0%
3 Month Change	n/a
1 Year Change	0%
33 Year Change	-99.00%
5 Year Change	-99.95%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	ADVT	US Pharmaceuticals	US Market
7D	0%	3.4%	1.6%
1Y	0%	14.2%	32.3%

Return vs Industry: ADVT underperformed the US Pharmaceuticals industry which returned 13.7% over the past year.

Return vs Market: ADVT underperformed the US Market which returned 32.4% over the past year.

Price Volatility

Is ADVT's price volatile compared to industry and market?
ADVT volatility
ADVT Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.0%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.2%
10% least volatile stocks in US Market	3.1%

Stable Share Price: ADVT's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine ADVT's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Darren Cherry	www.advantiscorp.com

Advantis Corp. develops and markets products focusing on medical cannabis, research, and pharmaceutical sectors. The company offers pain management and healthcare solutions. Advantis Corp. was formerly known as Ramoil Management, Ltd.

Advantis Corp. Fundamentals Summary

How do Advantis's earnings and revenue compare to its market cap?
ADVT fundamental statistics
Market cap	US$878.00
Earnings (TTM)	-US$294.93k
Revenue (TTM)	n/a

0.0x

P/S Ratio

0.0x

P/E Ratio

Is ADVT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ADVT income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$294.93k
Earnings	-US$294.93k

Last Reported Earnings

Dec 31, 2011

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did ADVT perform over the long term?

See historical performance and comparison